Antagonists against anti-apoptotic Bcl-2 family proteins for cancer treatment

Jignesh M. Doshi, Chengguo Xing

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Apoptosis is a programmed cell death process, critical for normal cellular development and tissue homeostasis. B-cell lymphocyte/leukemia 2 (Bcl-2) family proteins are important regulators of apoptosis. Numerous studies have demonstrated that over-expressing anti-apoptotic Bcl-2 proteins is one mechanism for cancer cells to acquire resistance against cancer chemotherapies, suggesting antagonizing these proteins would be a potential approach to overcoming such drug resistance. This review briefly discusses the principle and the recent advances in the development of such antagonists, with some highlights about several promising antagonists.

Original languageEnglish (US)
Pages (from-to)171-178
Number of pages8
JournalMini-Reviews in Organic Chemistry
Issue number3
StatePublished - Aug 28 2008


  • Apoptosis
  • Bcl-2 antagonists
  • Cancer
  • Drug resistance

Fingerprint Dive into the research topics of 'Antagonists against anti-apoptotic Bcl-2 family proteins for cancer treatment'. Together they form a unique fingerprint.

Cite this